Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand

Cancer Research

Volumn 60, Issue 12, 2000, Pages 3239-3246

  Mach, Nicolas ^a   Gillessen, Silke ^a   Wilson, S Brian ^a   Sheehan, Christine ^b   Mihm, Martin ^c   Dranoff, Glenn ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FLT3 LIGAND; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TUMOR VACCINE;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CELL MATURATION; CYTOKINE RELEASE; DENDRITIC CELL; FEMALE; GENE TRANSFER; IN VIVO STUDY; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR IMMUNITY;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, CD1; ANTIGENS, CD8; CANCER VACCINES; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; GENE TRANSFER TECHNIQUES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTEGRIN ALPHAXBETA2; INTERLEUKIN-5; MELANOMA; MELANOMA, EXPERIMENTAL; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RETROVIRIDAE; SPLEEN; T-LYMPHOCYTES; TH1 CELLS; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0034047619     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Steinman, R. M. The dendritic cell system and its role in immunogenicity. Ann. Rev. Immunol., 9: 271-296, 1991.
2. Banchereau, J., and Steinman, R. Dendritic cells and the control of immunity. Nature (Lond.), 392: 245-252, 1998.
3. Caux, C., Dezutter-Dambuyant, C., Schmitt, D., and Banchereau, J. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature (Lond.), 360: 258-261, 1992.
4. Inaba, K., Steinman, R., Witmer Pack, M., Aya, H., Inaba, M., Sudo, T., Wolpe, S., and Schuler, G. Identification of proliferating dendritic cell precursors in mouse blood. J. Exp. Med., 175: 1157-1167, 1992.
5. Reid, C., Stackpoole, A., Meager, A., and Tikerpae, J. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow. J. Immunol., 149: 2681-2688, 1992.
6. Scheicher, C., Mehlig, M., Zecher, R., and Reske, K. Dendritic cells from mouse bone marrow: in vitro differentiation using low doses of recombinant granulocyte-macrophage colony-stimulating factor. J. Immunol. Methods, 154: 253-264, 1992.
7. Young, J. W., and Inaba, K. Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity. J. Exp. Med., 183: 7-11, 1996.
8. Mayordomo, J. T., Zorina, T., Storkus, W. J., Zitvogel, L., Celluzzi, C., Falo, L. D., Melief, C. J., Ildstad, S. T., Kast, W. M., DeLeo, A. B., and Lotze, M. T. Bone marrow derived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic anti-tumor immunity. Nat. Med., 1: 1297-1302, 1995.
9. Zitvogel, L., Mayordomo, J. I., Tjandrawan, T., Deleo, A. B., Clarke, M. R., Lotze, M. T., and Storkus, W. J. Therapy of murine tumors with tumor peptide-pulsed dendritic cells - dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J. Exp. Med., 183: 87-97, 1996.
10. Paglia, P., Chiodoni, C., Rodolfo, M., and Colombo, M. P. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J. Exp. Med., 183: 317-322, 1996.
11. Boczkowski, D., Nair, S. K., Snyder, D., and Gilboa, E. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J. Exp. Med., 184: 465-472, 1996.
12. Hsu, F., Benike, C., Fagnoni, F., Liles, T., Czerwinski, D., Taidi, B., Engleman, E., and Levy, R. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat. Med., 2: 52-58, 1996.
13. Nestle, F., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G., and Schadendorf, D. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat. Med., 4: 328-332, 1998.
14. Maraskovsky, E., Brasel, K., Teepe, M., Roux, E., Lyman, S., Shortman, K., and McKenna, H. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med., 184: 1953-1961, 1996.
15. Pulendran, B., Lingappa, J., Kennedy, M., Smith, J., Teepe, M., Rudensky, A., Maliszewski, C., and Maraskovsky, E. Developmental pathways of dendritic cells in vivo. Distinct function, phenotype, and localization of dendritic cell subsets in flt3 ligand-treated mice. J. Immunol., 159: 2222-2231, 1997.
16. Shurin, M., Pandharipande, P., Zorina, T., Haluszczak, C., Subbotin, V., Hunter, O., Brumfield, A., Storkus, W., Maraskovsky, E., and Lotze, M. Flt3 ligand induces the generation of functionally active dendritic cells in mice. Cell. Immunol., 179: 174-184, 1997.
17. Pulendran, B., Smith, J., Caspary, G., Brasel, K., Pettit, D., Maraskovsky, E., and Maliszewski, C. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Natl. Acad. Sci. USA, 96: 1036-1041, 1999.
18. Lynch, D., and reasen, A., Maraskovsky, E., Whitmore, J., Miller, R., and Schuh, J. Flt3 ligand induces tumor regression and antitumor immune responses in vivo. Nat. Med., 3: 625-631, 1997.
19. Esche, C., Subbotin, V., Maliszewski, C., Lotze, M., and Shurin, M. Flt3 ligand administration inhibits tumor growth in murine melanoma and lymphoma. Cancer Res., 58: 380-383, 1998.
20. Chen, K., Braun, S., Lyman, S., Fan, Y., Traycoff, C., Wiebke, E., Gaddy, J., Sledge, G., Broxmeyer, H., and Cornetta, K. Antitumor activity and immunotherapeutic properties of Flt3-ligand in a murine breast cancer model. Cancer Res., 57: 3511-3516, 1997.
21. Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V., Hamada, H., Pardoll, D., and Mulligan, R. C. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA, 90: 3539-3543, 1993.
22. Soiffer, R., Lynch, T., Mihm, M., Jung, K., Rhuda, C., Schmollinger, J., Hodi, F., Liebster, L., Lam, P., Mentzer, S., Singer, S., Tanabe, K., Cosimi, A., Duda, R., Sober, A., Bhan, A., Daley, J., Neuberg, D., Parry, G., Rokovich, J., Richards, L., Drayer, J., Berns, A., Clift, S., Cohen, L., Mulligan, R., and Dranoff, G. Vaccination with irradiated, autologous melanoma cells engineered to secrete human granulocyte-macrophage colony stimulating factor generates potent anti-tumor immunity in patients with metastatic melanoma. Proc. Natl. Acad. Sci. USA. 95: 13141-13146, 1998.
23. Lyman, S. D., James, L., Bos, T. V., de Vries, P., Brasel, K., Gliniak, B., Hollingsworth, L. T., Picha, K. S., McKenna, H. J., Splett, R. R., Fletcher, F. A., Maraskovsky, E., Farrah, T., Foxworthe, D., Williams, D. E., and Beckmann, M. P. Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells. Cell. 75: 1157-1167, 1993.
24. Ory, D. S., Neugeboren, B. A., and Mulligan, R. C. A stable human-derived packaging cell line for production of high liter retrovirus/vesicular stomatitis virus G pseudotypes. Proc. Natl. Acad. Sci. USA, 93: 11400-11406, 1996.
25. Hartman, S. C., and Mulligan, R. C. Two dominant-acting selectable markers for gene transfer studies in mammalian cells. Proc. Natl. Acad. Sci. USA, 85: 8047-8051, 1988.
26. Brasel, K., McKenna, H., Morrissey, P., Charrier, K., Morris, A., Lee, C., Williams, D., and Lyman, S. Hematologic effects of flt3 ligand in vivo in mice. Blood, 88: 2004-2012, 1996.
27. Vremec, D., and Shortman, K. Dendritic cell subtypes in mouse lymphoid organs. Cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. J. Immunol., 159: 565-573, 1997.
28. Cella, M., Sallusto, F., and Lanzavecchia, A. Origin, maturation, and antigen presenting function of dendritic cells. Curr. Opin. Immunol., 9: 10-16, 1997.
29. α 14 NKT cells in IL-12-mediated rejection of tumors. Science (Washington DC), 278: 1623-1626, 1997.
30. α 14 NKT cells by glycosylceramides. Science (Washington DC), 278: 1626-1629, 1997.
31. Joyce, S., Woods, A., Yewdell, J., Bennick, J., Dharshan De Silva, A., Boesteanu, A., Balk, S., Cotter, R., and Brutkiewicz, R. Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol. Science (Washington DC), 279: 1541-1544, 1998.
32. Metcalf, D., Shortman, K., Vremec, D., Mifsud, S., and Di Rago, L. Effects of excess GM-CSF levels on hematopoiesis and leukemia development in GM-CSF/max 41 double transgenic mice. Leukemia (Baltimore), 10: 713-719, 1996.
33. Kaplan, G., Walsh, G., Guido, L., Meyn, P., Burkhardt, R., Abalos, R., Barker, J., Frindt, P., Fajardo, T., Celona, R., and Cohn, Z. Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing. J. Exp. Med., 175: 1717-1728, 1992.
34. Dranoff, G., Crawford, A. D., Sadelain, M., Ream, B., Rashid, A., Bronson, R. T., Dickersin, G. R., Bachurski, C. J., Mark, E. L., Whitsett, J. A., and Mulligan, R. C. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science (Washington DC), 264: 713-716, 1994.
35. Vremec, D., Lieschke, G., Dunn, A., Robb, L., and Shortman, K. The influence of granulocyte-macrophage colony-stimulating factor on dendritic cell levels in mouse lymphoid organs. Eur. J. Immunol., 27: 40-44, 1997.
36. Witmer-Pack, M., Olivier, W., Valinsky, J., Schuler, G., and Steinman, R. Granulocyte-macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells. J. Exp. Med., 166: 1484-1498, 1987.
37. O'Doherty, U., Steinman, R., Peng, M., Cameron, P., Gezelter, S., Kopeloff, I., Swiggard, W., Pope, M., and Bhardwaj, N. Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium. J. Exp. Med., 178: 1067-1078, 1993.
38. Sallusto, F., and Lanzavecchia, A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregutated by tumor necrosis factor α. J. Exp. Med., 179: 1109-18, 1994.
39. Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Van Kooten, C., Durand, I., and Banchereau, J. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med., 180: 1263-1272, 1994.
40. De Smedt, T., Pajak, B., Muraille, E., Lespagnard, L., Heinen, E., De Baetselier, P., Urbain, J., Leo, O., and Moser, M. Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J. Exp. Med., 184: 1413-1424, 1996.
41. Reis e Sousa, C., Hieny, S., Scharton-Kersten, T., Jankovic, D., Charest, H., Germain, R., and Sher, A. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J. Exp. Med., 186: 1819-1829, 1997.
42. Roake, J., Rao, A., Morris, P., Larsen, C., Hankins, D., and Austyn, J. Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin-1. J. Exp. Med., 181: 2237-2247, 1995.
43. Gunn, M., Kyuwa, S., Tam, C., Kakiuchi, T., Matsuzawa, A., Williams, L., and Nakano, H. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med., 189: 451-460, 1999.
44. Disis, M. L., Bernhard, H., Shiota, F. M., Hand, S. L., Gralow, J. R., Huseby, E. S., Gillis, S., and Cheever, M. A. Granulocyte-macrophage colony-stimulating factor - an effective adjuvant for protein and peptide-based vaccines. Blood, 88: 202-210, 1996.
45. Morrissey, P., Bressler, L., Park, L., Alpert, A., and Gillis, S. Granulocyte-macrophage colony-stimulating factor augments the primary antibody response by enhancing the function of antigen-presenting cells. J. Immunol., 139: 1113-1119, 1987.
46. Jager, E., Ringhoffer, M., Dienes, H. P., Arand, M., Karbach, J., Jager, D., Ilsemann, C., Hagedorn, M., Oesch, F., and Knuth, A. Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo. Int. J. Cancer, 67: 54-62, 1996.
47. Pulendran, B., Smith, J., Jenkins, M., Schoenborn, M., Maraskovsky, E., and Maliszewski, C. Prevention of peripheral tolerance by a dendritic cell growth factor: Flt3 ligand as an adjuvant. J. Exp. Med., 188: 2075-2082, 1998.
48. + T cells in the antitumor immune response. J. Exp. Med., 188: 2357-2368, 1998.
49. - subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J. Exp. Med., 189: 587-592, 1999.
50. + dendritic cells generate an immune response after subcutaneous injection without homing to the draining lymph node. J. Exp. Med., 189: 593-598, 1999.
51. Huang, A. Y., Golumbek, P., Ahmadzadeh, M., Jaffee, E., Pardoll, D., and Levitsky, H. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science (Washington DC), 264: 961-965, 1994.
52. Albert, M., Sauter, B., and Bhardwaj, N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. J. Exp. Med., 392: 86-89, 1998.
53. 5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med., 188: 1359-1368, 1998.
54. Inaba, K., Turley, S., Yamaide, F., Iyoda, T., Mahnke, K., Inaba, M., Pack, M., Subklewe, M., Sauter, B., Sheff, D., Albert, M., Bhardwaj, N., Mellman, I., and Steinman, R. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J. Exp. Med., 188: 2163-2173, 1998.
55. Chiodoni, C., Paglia, P., Stoppacciaro, A., Rodolfo, M., Parenza, M., and Colombo, M. Dendritic cells infiltrating tumors cotransduced with granulocyte/macrophage colony-stimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte response. J. Exp. Med., 190: 125-133, 1999.
56. Shen, Z., Reznikoff, G., Dranoff, G., and Rock, K. Cloned dendritic cells can present exogenous antigens on both MHC class I and II molecules. J. Immunol., 158: 2723-2730, 1997.
57. Larsen, C. P., Ritchie, S. C., Hendrix, R., Linsley, P. S., Hathcock, K. S., Hodes, R. J., Lowry, R. P., and Pearson, T. C. Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J. Immunol., 152: 5208-5219, 1994.
58. Murtaza, A., Kuchroo, V., and Freeman, G. Changes in the strength of co-stimulation through the B7/CD28 pathway alter functional T cell responses to altered peptide ligands. Int. Immunol., 11: 407-416, 1999.
59. Freeman, G., Borriello, F., Hodes, R., Reiser, H., Gribben, J., Ng, J., Kim, J., Goldberg, J., Hathcock, K., Lombard, L., Wang, S., Gray, G., Nadler, L., and Sharpe, A. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science (Washington DC), 262: 907-909, 1993.
60. Mackey, M., Gunn, J., Ting, P., Kikutani, H., Dranoff, G., Noelle, R., and Barth, R. Protective immunity induced by tumor vaccines requires interaction between CD40 and its ligand, CD154. Cancer Res., 57: 2569-2574, 1997.
61. Bendelac, A., Rivera, M., Park, S-H., and Roark, J. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol., 15: 535-562, 1997.
62. + T cell development and early IL-4 production in CD1-deficient mice. Immunity, 6: 459-467, 1997.
63. Mendiratta, S., Martin, W., Hong, S., Boesteanu, A., Joyce, S., and Van Kaer, L. CD1d mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity, 6: 469-477, 1997.
64. Smiley, S., Kaplan, M., and Grusby, M. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Science (Washington DC), 275: 977-979, 1997.
65. Reddy, A., Sapp, M., Feldman, M., Subklewe, M., and Bhardwaj, N. A monocyte conditioned medium is more effective than defined cytokines in mediating the terminal maturation of human dendritic cells. Blood, 90: 3640-3646, 1997.
66. Inaba, K., Inaba, M., Deguchi, M., Hagi, K., Yasumizu, R., Ikehara, S., Muramatsu, S., and Steinman, R. Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class 11-negative progenitor in mouse bone marrow. Proc. Natl. Acad. Sci. USA, 90: 3038-3042, 1993.